Trials / Conditions / Epithelioid Sarcoma

Epithelioid Sarcoma

19 registered clinical trials studyying Epithelioid Sarcoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190	University of Florida	Phase 1 / Phase 2
Recruiting	MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154	HRYZ Biotech Co.	Phase 2
Active Not Recruiting	Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors NCT05407441	Susan Chi, MD	Phase 1 / Phase 2
Active Not Recruiting	Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors NCT05286801	National Cancer Institute (NCI)	Phase 1 / Phase 2
Unknown	Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas NCT05415098	Ascentage Pharma Group Inc.	Phase 1
Recruiting	Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Proje NCT03967834	Institut Claudius Regaud	N/A
Recruiting	Evaluate the Safety and Clinical Activity of HH2853 NCT04390737	Haihe Biopharma Co., Ltd.	Phase 1 / Phase 2
Active Not Recruiting	Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers NCT04416568	Dana-Farber Cancer Institute	Phase 2
Completed	Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patie NCT04008238	Institut Bergonié	N/A
Completed	Epithelioid Sarcoma Natural History Study NCT03837678	Epizyme, Inc.	—
Completed	Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers NCT03190174	Sarcoma Oncology Research Center, LLC	Phase 1 / Phase 2
Recruiting	An Observational Study on Epithelioid Sarcoma NCT03099681	Italian Sarcoma Group	—
Active Not Recruiting	A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/ NCT03069378	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma NCT02584309	Washington University School of Medicine	Phase 2
Completed	A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma NCT02601950	Epizyme, Inc.	Phase 2
Active Not Recruiting	Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867	National Cancer Institute (NCI)	Phase 2 / Phase 3
Completed	Trial of Dasatinib in Advanced Sarcomas NCT00464620	Sarcoma Alliance for Research through Collaboration	Phase 2
No Longer Available	Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma NCT04225429	Epizyme, Inc.	—
Available	Compassionate Use of Ubamatamab NCT07502716	Regeneron Pharmaceuticals	—